Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 11779691000202117 | Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 11794341000202114 | Clioquinol 30 mg/g and fluocinolone acetonide 250 microgram/g cutaneous cream | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5980941000052112 | fluocinolonacetonid 250 mikrog/g och kliokinol 30 mg/g, hudkräm | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Is a | Product containing only clioquinol and fluocinolone in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has manufactured dose form | Cutaneous cream | true | Inferred relationship | Some | ||
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Plays role | Antiprotozoal therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Clioquinol (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Clioquinol (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has precise active ingredient | Fluocinolone acetonide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has basis of strength substance (attribute) | Fluocinolone acetonide (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely clioquinol 30 milligram/1 gram and fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous cream (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR